Evid Invest
Who owns BBOTWhat BBOT owns — n/a

Who owns BridgeBio Oncology Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of BBOT from SEC Form 13F filings across 89 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 89 institutions disclosed 60.3M shares of BridgeBio Oncology Therapeutics, Inc. worth $247.1M — about 75.2% of shares outstanding; the largest disclosed holder is Cormorant Asset Management, LP. Source: SEC Form 13F filings, parsed by EvidInvest.

89

13F holders

$247.1M

value, 2026 filers

75.2%

of shares outstanding (60.3M sh)

33

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of BBOT's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1Cormorant Asset Management, LP17.9M$73.3M4.9%22.3%0.0%
2BlackRock, Inc.4.0M$16.4M0.0%5%+86.2%
3Omega Fund Management, LLC3.3M$13.5M10.8%4.1%0.0%
4DEERFIELD MANAGEMENT COMPANY, L.P.3.1M$12.9M0.2%3.9%-35.8%
5Alphabet Inc.2.8M$11.6M0.0%3.5%0.0%
6CITADEL ADVISORS LLC2.7M$11.1M0.0%3.4%+3.0%
7ENAVATE SCIENCES GP, LLC2.6M$10.8M3.8%3.3%0.0%
8REGENTS OF THE UNIVERSITY OF CALIFORNIANEW2.5M$10.3M0.2%3.1%new
9ARMISTICE CAPITAL, LLC2.3M$9.3M0.1%2.8%+28.3%
10NOVO HOLDINGS A/S2.3M$9.2M0.6%2.8%0.0%
11Laurion Capital Management LP2.0M$8.2M0.1%2.5%0.0%
12VANGUARD CAPITAL MANAGEMENT LLC2.0M$8.2M0.0%2.5%-0.7%
13WELLINGTON MANAGEMENT GROUP LLP1.4M$5.9M0.0%1.8%-48.7%
14Aisling Capital Management LP1.0M$4.1M1.4%1.3%0.0%
15STATE STREET CORP893,262$3.7M0.0%1.1%-13.8%
16EcoR1 Capital, LLC889,607$3.6M0.2%1.1%-68.5%
17Catalio Capital Management, LP699,532$2.9M0.5%0.9%+119.7%
18Opaleye Management Inc.630,000$2.6M0.3%0.8%-10.0%
19GEODE CAPITAL MANAGEMENT, LLC556,989$2.3M0.0%0.7%-10.5%
20MARSHALL WACE, LLPNEW482,935$2.0M0.0%0.6%new
21SPHERA FUNDS MANAGEMENT LTD.464,480$1.9M0.3%0.6%+0.8%
22Granahan Investment Management, LLC437,004$1.8M0.1%0.5%-21.8%
23ADAGE CAPITAL PARTNERS GP, L.L.C.400,000$1.6M0.0%0.5%0.0%
24BNP PARIBAS FINANCIAL MARKETS349,576$1.4M0.0%0.4%+82.9%
25PRICE T ROWE ASSOCIATES INC /MD/298,798$1.2M0.0%0.4%-0.4%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.